Company / Current Liabilities per Share
Bristol Myers Squibb Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$11.27
FY2025
5-year range
$9.69 / $12.77
FY2021-FY2025
Trend
+1.7%
vs FY2024
Sector context
#21 of 210
Health Care
What the data says
Among 210 Health Care companies, Bristol Myers Squibb is in the bottom 10% for current liabilities per share. Current Liabilities per Share has increased for 3 consecutive years, from $9.69 in FY2022 to $11.27 in FY2025.
Based on SEC 10-K filings.
11.27 in FY2025 with a 5-year CAGR of -0.7%. Top quartile in the Health Care sector.
Increased from $9.92 to $11.27 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +5.1%
- 5-Year CAGR
- -0.7%
- 10-Year CAGR
- -
Sector benchmark
-52.6% below sector average
Key checks
Key Insights
- Bristol Myers Squibb's current liabilities per share has grown for 3 consecutive years.
- In FY2025, current liabilities per share increased 1.7% year-over-year.
- Ranks #21 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.27 | +1.7% |
| FY2024 | $11.08 | +11.7% |
| FY2023 | $9.92 | +2.3% |
| FY2022 | $9.69 | -24.1% |
| FY2021 | $12.77 | +9.6% |
| FY2020 | $11.66 | +5.2% |
| FY2019 | $11.08 | +74.7% |
| FY2018 | $6.34 | +11.3% |
| FY2017 | $5.70 | +7.6% |
| FY2016 | $5.29 | +9.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026